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Molecular mechanisms of glucose action on angiotensinogen Hyperglycemia has been implicated in the etiology of
gene expression in rat proximal tubular cells. diabetic nephropathy [1]. However, the molecular mech-
Background. Clinical studies have shown that the angioten- anisms linking hyperglycemia to the development of ne-sin-converting enzyme (ACE) inhibitors or angiotensin II (Ang
phropathy are not completely understood. Clinical stud-II) receptor antagonists decrease proteinuria and slow the pro-
ies have shown that inhibitors of angiotensin-convertinggression of nephropathy in diabetes, indicating that Ang II
plays an important role in the development of nephropathy. enzyme (ACE) or angiotensin II (Ang II) receptor an-
We have previously reported that high levels of glucose stimu- tagonists decrease proteinuria and slow the progression
late the expression of rat angiotensinogen (ANG) gene in opos-
of nephropathy in diabetic patients [2–9], indicating thatsum kidney (OK) proximal tubular cells. We hypothesized that
Ang II plays an important role in this intractable dis-the stimulatory effect of d(1)-glucose on the expression of the
ANG gene in kidney proximal tubular cells is mediated via de order.
novo synthesis of diacylglycerol (DAG) and the protein kinase Indeed, in vitro studies have shown that high levels of
C (PKC) signal transduction pathway. glucose or Ang II stimulate the proliferation of mesan-Methods. Immortalized rat proximal tubular cells (IRPTCs)
gial cells and the expression of the mRNA of extracellu-were cultured in monolayer. The stimulatory effect of glucose
on the activation of polyol pathway and PKC signal transduc- lar matrix proteins [10–13]. Similarly, incubation of mu-
tion pathway in IRPTCs was determined. The immunoreactive rine proximal tubular cells in a high glucose medium or
rat ANG (IR-rANG) in the culture medium and the cellular in the presence of Ang II ($1028 m) induces cellularANG mRNA were measured with a specific radioimmunoassay
hypertrophy and extracellular matrix protein synthesisand a reverse transcription-polymerase chain reaction assay,
[14–21]. Although the results from these studies indicaterespectively.
Results. d(1)-glucose (25 mm) markedly increased the intra- that elevated glucose and/or Ang II concentrations may
cellular levels of sorbitol, fructose, DAG, and PKC activity as be responsible for the development of diabetic nephrop-
well as the expression of IR-rANG and ANG mRNA in
athy, the mechanisms are poorly understood but mayIRPTCs. These stimulatory effects of d(1)-glucose (25 mm)
involve increased polyol pathway or protein kinase Cwere blocked by an inhibitor of aldose reductase, Tolrestat.
PKC inhibitors also inhibited the stimulatory effect of d(1)- (PKC) activity. Indeed, inhibitors of the polyol pathway,
glucose (25 mm) on the expression of the IR-rANG in IRPTCs. as well as protein kinase C antagonists, have prevented
The addition of phorbol 12-myristate 13-acetate further en- glomerular hyperfiltration and have increased urinaryhanced the stimulatory effect of d(1)-glucose (25 mm) on the
albumin excretion in diabetic rats [22, 23].expression of the IR-rANG in IRPTCs and blocked the inhibi-
tory effect of Tolrestat. The mRNA components of the renin-angiotensin sys-
Conclusion. These studies suggest that the stimulatory effect tem (RAS), including angiotensinogen (ANG), renin,
of a high level of d(1)-glucose (25 mm) on the expression of ACE, and Ang II receptor (AT1-receptor), are expressedthe ANG gene in IRPTCs is mediated, at least in part, via
in murine (mouse and rat) immortalized proximal tubu-the de novo synthesis of DAG, an activator of PKC signal
lar cell lines [24–27]. We have recently reported that thetransduction pathway.
ANG protein is secreted from rat immortalized proximal
tubular cells as measured by a specific radioimmunoassayKey words: hyperglycemia, renin-angiotensin system, diabetic ne-
phropathy, polyol pathway. for rat ANG (RIA-rANG) [28], providing evidence that
the intrarenal Ang II is derived from the ANG that isReceived for publication June 9, 1998
synthesized within the renal proximal tubular cells.and in revised form September 2, 1998
Accepted for publication September 3, 1998 In these studies, we have characterized the effect of
glucose on the expression of the ANG gene in immortal- 1999 by the International Society of Nephrology
454
Zhang et al: Tolrestat, PKC and ANG gene in proximal tubular cells 455
ized rat proximal tubular cells (IRPTCs). Our results in 100 3 20 mm plastic Petri dishes (Life Technologies
show that the expression of the ANG in IRPTCs was Inc.) in low glucose (5 mm) Dulbecco’s modified Eagle’s
stimulated by high concentrations (25 mm) of d(1)-glu- medium (DMEM; pH 7.45) supplemented with 10% fe-
cose but not by d-mannitol, l-glucose or 2-deoxy-d-glu- tal bovine serum (FBS), 100 U/ml of penicillin, and 100
cose. Furthermore, the addition of Tolrestat (an inhibitor mg/ml of streptomycin. The cells were grown in a humidi-
of aldose reductase) or staurosporine (an inhibitor of fied atmosphere in 95% air, 5% CO2 at 378C. For subcul-
PKC) or H-7 (an inhibitor of PKC) blocked the stimula- turing, cells were trypsinized [0.05% trypsin and ethyl-
tory effect of glucose. In contrast, the addition of phorbol enediaminetetraacetic acid (EDTA)] and were plated at
12-myristate 13-acetate (PMA; a PKC activator) en- 2.5 3 104 cells/cm2 in 100 3 20 mm Petri dishes.
hanced the stimulatory effect of glucose and blocked
Effect of D(1)-glucose on the expression ofthe inhibitory effect of Tolrestat. Finally, a high glucose
immunoreactive rat ANG in IRPTCsconcentration in the culture media increased intracellu-
lar levels of sorbitol, fructose, diacylglycerol (DAG), and Immortalized rat proximal tubular cells were plated
PKC activity, as well as the expression of ANG mRNA at a density of 1 to 2 3 105 cells/well in six-well plates
in IRPTCs. All of these effects of glucose were blocked and were incubated overnight in low-glucose DMEM
by Tolrestat. containing 10% FBS. Then cell growth was arrested by
incubating the cells in serum-free medium with low-glu-
cose DMEM for 24 hours. Various concentrations ofMETHODS
d(1)-glucose (final concentration 5 to 25 mm) were then
d(1)-glucose, l-glucose, d-mannitol, 2-deoxy-d-glu-
added to the culture medium containing 1% depletedcose, and staurosporine (an inhibitor of PKC) were pur-
FBS, and the cells were incubated for an additional 24chased from Sigma Chemical (St. Louis, MO, USA). H-7
hours. To maintain a constant tonicity, the media were(an inhibitor of PKC) was purchased from Research
supplemented with d-mannitol, 15 to 25 mm (final con-Biochemicals Inc. (Natick, MA, USA). Tolrestat (an in-
centration). At the end of the incubation period, mediahibitor of aldose reductase) was a gift from Wyeth-
were collected and stored at 2208C until assayed forAyerst Research (Princeton, NJ, USA).
immunoreactive rat ANG (IR-rANG).Gamma-[32P-ATP] (3000 Ci/mol) and Na125I were pur-
To determine the specificity of d(1)-glucose, 5 or 25chased from Dupont, New England Nuclear (Boston,
mm of l-glucose or d-mannitol or 2-deoxy-d-glucoseMA, USA). Restriction and modifying enzymes were
were added to the culture medium, and the cells werepurchased from either Life Technologies Inc. (Burl-
treated as described earlier here.ington, Ontario, Canada), Boehringer-Mannheim (Dor-
The depleted FBS was prepared by incubation withval, Quebec, Canada), or Pharmacia Inc. (Baie d’Urfe´,
1% activated charcoal and 1% AG 1 3 8 ion-exchangeQuebec, Canada).
resin (Bio-Rad Laboratories, Richmond, CA, USA) for
16 to 24 hours at room temperature as Samuels, StandbyRadioimmunoassay for rat angiotensinogen
and Shapiro described [29]. This procedure removes en-The radioimmunoassay for rat ANG (RIA-rANG)
dogenous steroid and thyroid hormones from the FBSwas developed in our laboratory (by J.S.D. Chan), and
as Samuels et al demonstrated [29].the procedure has been previously described [28]. Puri-
fied rat plasma ANG [that is, greater than 90% pure, as Effect of Tolrestat, staurosporine, H-7, or PMA
analyzed by polyacrylamide gel electrophoresis con- on the expression of IR-rANG in IRPTCs in
taining sodium dodecyl sulfate (SDS-PAGE)] and the the presence of high glucose
iodinated rANG were used as the hormone standard
To study the effects of the PKC signal transductionand tracer, respectively. This RIA is specific for intact
pathway and the polyol pathway on the expression ofrat ANG (62 to 65 kDa rANG) and has no cross-reactiv-
IR-rANG in IRPTCs, various concentrations of Tolres-ity with pituitary hormone preparations or other rat
tat (1027 to 1024 m), staurosporine (10211 to 1025 m), H-7plasma proteins [28]. The lower limit of detection for
(10211 to 1025 m), or PMA (10211 to 1025 m) were addedthe RIA is approximately 2 ng of rANG. The intra-assay
to the media together with d(1)-glucose (25 mm), andand interassay coefficients of variation were 9% (N 5
the cells were then incubated for 24 hours. At the end of10) and 14% (N 5 10), respectively.
the incubation period, media were collected and stored at
Cell culture 2208C until assayed for IR-rANG.
To investigate the antagonistic effect of Tolrestat andImmortalized rat proximal tubular cells at passages 11
PMA on the expression of IR-rANG in IRPTCs, variousto 13 were used in these studies. The characteristics of
concentrations of PMA (10211 to 1027 m), were addedthe IRPTCs have been previously described [28]. These
with Tolrestat (1024 m) to the culture media, and thecells express the mRNA and protein of ANG, renin,
cells were again incubated for 24 hours in the presenceACE, and Ang II receptor [27, 28].
Immortalized rat proximal tubular cells were grown of 25 mm d(1)-glucose. At the end of the incubation
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period, media were collected and kept at 2208C until
assayed for IR-rANG.
Effect of D(1)-glucose and Tolrestat on the
intracellular levels of cellular sorbitol, fructose,
DAG, and PKC activity in IRPTCs
To study the effect of Tolrestat on the d(1)-glucose
stimulation of cellular sorbitol, fructose, DAG, and PKC
activity in IRPTCs, 1 to 2 3 106 cells were plated in 20 3
100 mm Petri dishes and were incubated overnight in
DMEM containing 5 mm d(1)-glucose and 10% FBS.
Cell growth was then arrested by incubating the cells in
serum-free media with low d(1)-glucose (5 mm) for 24
hours. Subsequently, the cells were incubated in media
Fig. 1. Effect of D(1)-glucose on the expression of rat angiotensinogenwith 5 mm d(1)-glucose, 25 mm d(1)-glucose, or 25 mm (ANG) in immortalized rat proximal tubule cells (IRPTCs). Cells were
d(1)-glucose plus Tolrestat (1024 m) for 30 minutes (that incubated to 24 hours in the presence of various concentrations of d(1)-
glucose. Media were collected and assayed for immunoreactive rat ANGis, for the DAG assay), one hour (PKC assay), or 24
(IR-rANG). The concentration of IR-rANG in the medium containinghours (sorbitol and fructose assays). At the end of the low d(1)-glucose (5 mm; that is, 2.75 6 0.05 ng/ml) was considered as
incubation period, cells were collected and immediately the control level (100%). Each point represents the mean 6 sd of three
dishes (**P # 0.01 and ***P # 0.005). Similar results were obtainedanalyzed for DAG or PKC activity, or were stored at
from three independent experiments.2808C for subsequent analysis of sorbitol and fructose.
Assays for cellular sorbitol, fructose, DAG, and
PKC activity
into cytosolic and membrane fractions. Briefly, the cells
The methods for the assays of cellular sorbitol, fruc- were harvested in 3 ml of buffer A [20 mm Tris-HCl, pH
tose, and myoinositol have been described previously 7.5, containing 2 mm EDTA, 0.5 mm ethylene glycol-bis
[30]. Briefly, confluent cells were rinsed three times with (b-aminoethyl ether)-N,N,N;N9-tetraacetic acid], 1 mm
phosphate-buffered saline and were sonicated for five
phenyl methyl sulfonyl fluoride, 1 mm dithiothreitol, 25
seconds at approximately 30% of the duty cycle. The
mg/ml leupeptin, 1 mg/ml pepstatin A, and 330 mm sucrose]cells extracts were snap frozen in liquid nitrogen and
and kept on ice. Then, cells were homogenized with awere stored at 2208C. Deuterium-labeled sorbitol (Iso-
Douce-bound glass homogenizer (type B) and centri-tec, Miamisburg, OH, USA) and myoinositol (Merck
fuged at 100,000 3 g for 30 minutes at 48C. FollowingIsotopes, Montreal, Canada) were added as internal stan-
centrifugation, the supernatants (cytosolic fraction) weredards to the thawed samples. The samples were then
stored on ice until assay. The pellets were resuspendeddeproteinized with 5% trichloroacetic acid, extracted
in 3 ml of buffer B (20 mm Tris-HCl, pH 7.5, 2 mmwith ether, lyophilized, derivatized with hydroxylamine
EDTA, 0.5 mm EGTA, 1 mm phenyl methyl sulfonylhydrochloride, 4-(dimethylamino) pyridine, and acetic
fluoride, 1 mm DTT, 25 mg/ml leupeptin, 1 mg/ml pep-anhydride, and were injected into a gas chromatograph
statin A, and 0.2% Triton X-100) and were incubated onequipped with a SPB-1 fused silica capillary column (Su-
ice with agitation for 30 minutes. Finally, the suspensionspelco, Bellefonte, PA, USA). Concentrations were calcu-
were centrifuged at 100,000 3 g for 30 minutes, and thelated on the basis of an eight-point standard curve con-
supernatants were collected as the membrane fractionstructed by the addition of varying amounts glucose,
and were stored on ice until assayed by the PKC assaysorbitol, and myoinositol to samples of cells grown in
kit. The PKC activity in the cytosolic and membranemedia with 5 mm glucose. Processing and analysis were
fractions was expressed as pmol of 32P-ATP incorporatedidentical to those used for the unknown samples. This
per minute per milligram of protein.technique gave an instrument response that was linear
for polyol concentrations ranging 0.05 mg to 20 mg per
Effect of D(1)-glucose and Tolrestat onsample. Hexose and polyol concentrations in cultured
the expression of ANG mRNA in IRPTCscells were expressed as nmol/mg protein.
To study the effect of d(1)-glucose on the expressionThe DAG assay kit (RPN 200) was purchased from
of ANG mRNA in the absence or presence of Tolrestat,Amersham Life Science (Oakville, Ontario, Canada). The
IRPTCs were incubated in 5 mm d(1)-glucose, 25 mmmethods for the assay of DAG in IRPTCs were performed
d(1)-glucose, or 25 mm d(1)-glucose plus Tolrestat (1024 m)according to the protocol provided by the supplier.
for 24 hours. At the end of the incubation period, cellsThe PKC activity was measured according to the man-
were collected, and total RNA was extracted. One micro-ufacturer’s protocol (RPN 77; Amersham Life Science).
Prior to the assay, however, the IRPTCs were separated gram aliquot of total RNA was used in reverse transcrip-
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Fig. 2. Effect of D(1)-glucose, D-mannitol,
L-glucose, and 2-deoxy D(1)-glucose on the
expression of rat ANG in IRPTCs. Cells were
incubated for 24 hours in the presence of low
(5 mm) or high (25 mm) concentration of d(1)-
glucose, d-mannitol, l-glucose, and 2-deoxy
d(1)-glucose. Media were harvested after 24
hours of incubation and were assayed for IR-
rANG. The concentration of IR-rANG in the
medium containing 5 mm d(1)-glucose was
considered as the control level (that is, 100%).
Each point represents the mean 6 sd of three
dishes (***P # 0.005). Similar results were
obtained from three other experiments.
tion-polymerase chain reaction (RT-PCR) to quantitate the membrane was washed and exposed to autoradiogra-
phy. The relative densities of the PCR bands were deter-the amount of ANG mRNA expressed in the IRPTCs
mined with a computerized laser densitometer.as described later here.
Statistical analysisRT-PCR assay
Three to four separate experiments were performed,The RT-PCR assay was performed by using the for-
and each treatment group was assayed in triplicate. Theward primer, 59GAG GGG GTC AGC ACG GAC AGC
data were analyzed with the Student’s t-test or analysisACC 39, and the reversed primer, 59 GCC CAG AAA
of variance. A probability level of P # 0.05 was regardedGTG CAC CGC ACC TGA 39, corresponding to the
as statistically significant.nucleotide sequence of N1775 to N1798 and N11381
to N11404 of the rat ANG cDNA [31]. Briefly, the total
RNA was isolated from the IRPTCs using Trizol reagent RESULTS
(Life Technologies Inc.) according to the protocol of the Effects of D(1)-glucose on the expression of
supplier. The cDNAs were then synthesized using one ANG in IRPTCs
microgram of total RNA and the Super-Script preampli-
A concentration-dependent relationship betweenfication system, following the protocol described by the
d(1)-glucose levels and the stimulation of expression ofsupplier (Life Technologies Inc.). Then, 2 ml of the cDNA
the ANG was observed at glucose concentrations rang-reaction mixture was used to amplify the rat ANG cDNA
ing between 5 and 25 mm (Fig. 1). Twenty-five mm offragment using the PCR-core kit according to the proto-
d(1)-glucose stimulated the expression of the ANG by
col of the supplier (Boehringer-Mannheim Inc.). Further- 1.75-fold (P # 0.005).
more, primers specific for rat glyceraldehyde-phosphate Figure 2 compares the effect of 5 mm or 25 mm of d(1)-
dehydrogenase (G-3-PDH) [32] (forward and reversed glucose, d-mannitol, l-glucose, or 2-deoxy-d-glucose on
primers, 59 TCA CCA CCA TGG AAGA AGG CTG the expression of ANG in IRPTCs following a 24-hour
GGG CTC AC39and 59GTA GCC CAG GAT GCC CTT incubation. In contrast to d(1)-glucose, d-mannitol,
TAG 39 corresponding to nucleotides N1329 to N1357 l-glucose, or 2-deoxy-d-glucose at 25 mm had no signifi-
and N1834 to N1852 of rat G-3-PDH) were used in an- cant effect on the expression of ANG in IRPTCs com-
other PCR reaction as an internal control. The RT-PCR pared with those at 5 mm.
reaction mixture was then separated on a 1.5% agarose
Effect of Tolrestat, staurosporine, H-7, or PMA ongel and transferred onto a nitrocellulose membrane. Sub-
the expression of ANG in IRPTCs in the presencesequently, 32P-labeled oligonucleotides corresponding to
of high glucosethe nucleotide N1994 to N11020 of the rat ANG cDNA
[31] and the nucleotide of N1418 to N1448 of rat G-3- Figure 3 shows that the addition of Tolrestat (10213 to
1024 m) inhibited the stimulatory effect of 25 mm d(1)-PDH [32] were used to hybridize the membrane. Finally,
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Fig. 3. Inhibitory effect of Tolrestat on the expression of rat ANG in
IRPTCs cultured in the presence of 25 mM D(1)-glucose. Cells were
incubated for 24 hours in the presence of 5 mm or 25 mm d(1)-glucose
in the absence or presence of Tolrestat. Media were harvested and
assayed for the level of IR-rANG. The levels of IR-rANG in the medium
containing low d(1)-glucose (5 mm; that is, 3.25 6 0.05 ng/ml) were
considered as the controls (100%). The inhibitory effect of Tolrestat
is compared with cells that were incubated in 25 mm d(1)-glucose in
the absence of Tolrestat. Each point represents the mean 6 sd of three
dishes (*P # 0.05, **P # 0.01, and NS). Similar results were obtained
from three other experiments.
glucose on the expression of ANG in IRPTCs in a con-
centration-dependent manner with a maximal effective
inhibitory dose for Tolrestat at 1024 to 1025 m (P # 0.01).
The addition of staurosporine (10211 to 1025 m; Fig. 4A)
Fig. 4. Inhibitory effect of staurosporine or H-7 on the expression ofor H-7 (10211 to 1025 m; Fig. 4B) also inhibited the stimu-
rat ANG in IRPTCs stimulated by 25 mM D(1)-glucose. Cells werelatory effect of 25 mm d(1)-glucose on the expression
incubated for 24 hours in the presence of 5 mm or 25 mm d(1)-glucose
of ANG in IRPTCs in a dose-dependent manner. The in the absence or presence of staurosporine (A) or H-7 (B). The levels
of IR-rANG in the medium containing low d(1)-glucose (5 mm) in Ahalf-maximal and maximal inhibitory effects of stauro-
(3.69 6 0.11 ng/ml) or in B (3.49 6 0.08 ng/ml) were considered assporine or H-7 were at 1029 and 1025 m, respectively.
control (100%). The inhibitory effect of staurosporine or H-7 is com-
In contrast, the addition of PMA (10211 to 1025 m) pared with cells that were incubated in 25 mm d(1)-glucose (in the
absence of staurosporine or H-7). Each point represents the mean 6enhanced the stimulatory effect of 25 mm d(1)-glucose
sd of three dishes (**P # 0.01 and ***P # 0.005). Similar results wereon the expression of ANG in IRPTCs in a concentration-
obtained from three other experiments.
dependent manner (Fig. 5). The maximal enhancing ef-
fect on the expression of the ANG was observed with
1027 m PMA. At higher concentrations, the enhancing
effect of PMA appeared to be attenuated. with 25 mm d(1)-glucose was reversed in the presence
When cells were preincubated for 24 hours with 1025 of PMA. PMA, at a concentration of 1029 m, completely
m PMA (Fig. 6B) and were then exposed to 25 mm d(1)- blocked the inhibitory effect of Tolrestat (1024 m).
glucose or PMA (1027 m), the stimulatory effect of 25
Effect of D(1)-glucose and Tolrestat on the cellularmm of d(1)-glucose or 1027 m PMA on the expression
levels of sorbitol, fructose, DAG, and PKCof the ANG was lost (Fig. 6B) compared with the cells
activity in IRPTCswithout the preincubation with 1025 m PMA (Fig. 6A).
These studies suggest that the stimulatory effect of a Incubating IRPTCs for 24 hours in media with 25 mm
high glucose level (25 mm) on the expression of ANG d(1)-glucose led to increases of 5.63-fold and 33.9-fold
in IRPTCs may be mediated via the PKC signal transduc- in cellular levels of sorbitol and fructose, respectively
tion pathway. (Fig. 8). Tolrestat (1024 m) completely prevented the in-
creases in sorbitol but only partially attenuated the in-
Antagonistic effect of PMA and Tolrestat on the creases in fructose (that is, 80% inhibition). Myoinositol
expression of ANG in IRPTCs in the presence levels were unaffected by either high glucose or Tolrestat.
of high glucose Exposure to high glucose levels (25 mm) also increased
Figure 7 shows that the inhibitory effect of Tolrestat the intracellular level of DAG (Fig. 9) and membrane
PKC activity (Fig. 10). The addition of Tolrestat (1024 m)(1024 m) on the expression of ANG in IRPTCs treated
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Fig. 5. Stimulatory effect of phorbol 12-myristate 13-acetate (PMA)
Fig. 7. Effect of PMA on the expression of rat ANG in IRPTCs inon the expression of rat ANG in IRPTCs cultured in the presence of
the presence of 25 mM D(1)-glucose and Tolrestat. Cells were incubated25 mM D(1)-glucose. Cells were incubated for 24 hours in the presence
for 24 hours in the presence of 5 mm d(1)-glucose, 25 mm d(1)-glucose,of 5 mm or 25 mm d(1)-glucose in the absence or presence of PMA.
or 25 mm d(1)-glucose plus 1024 m Tolrestat in the absence or presenceMedia were harvested and assayed for the IR-rANG. Levels of IR-
of various concentrations of PMA (10211 to 1027 m). Media were har-rANG in the medium containing low d(1)-glucose (5 mm; 3.15 6 0.05
vested and assayed for the level of IR-rANG. Levels of IR-rANG inng/ml) in the absence of PMA were considered as control (100%). The
the medium containing low d(1)-glucose (5 mm; 4.15 6 0.1 ng/ml) instimulatory effect of PMA is compared with cells that were stimulated
the absence of Tolrestat or PMA were considered as the controlsby 25 mm d(1)-glucose. Each point represents the mean 6 sd of three
(100%). The effect of PMA is compared with cells that were incubateddishes (**P # 0.01 and ***P # 0.005). Similar results were obtained
in the presence of 25 mm d(1)-glucose and 1024 Tolrestat. Each pointfrom two other experiments.
represents the mean 6 sd of three dishes (**P # 0.01). Similar results
were obtained from another experiment.
to levels that were twofold higher than those in control
cells cultured in media containing 5 mm glucose (P #
0.05). Tolrestat (1024 m) inhibited the stimulatory effect of
high glucose (25 mm) on the expression of ANG mRNA.
DISCUSSION
Although several studies have investigated the rela-
tionship between diabetes and the expression of RAS
genes (that is, ANG, renin, ACE, and AT1-receptors) in
the kidney of rats, the results have been inconsistent
[33–35]. Correa-Rotter, Hostetter and Rosenberg [33]Fig. 6. Effect of D(1)-glucose on the expression of rANG in IRPTCs
preincubated with a high level of PMA. Cells were preincubated for and Kalinyak et al [34] reported that renal renin and
24 hours with 5 mm d(1)-glucose (A) or 5 mm d(1)-glucose and 1025 m ANG mRNA levels were not different between controlPMA (B). Then the media were replaced with fresh media containing
and diabetic rats. Anderson, Jung and Ingelfinger, how-5 mm d(1)-glucose, 25 mm d(1)-glucose, or 25 mm d(1)-glucose plus
1027 PMA and were incubated for an additional 24 hours. Then the ever, have found a small but significant increase in renal
media were harvested and assayed for immunoreactive rANG (IR- renin and ANG gene expression in diabetic rats [35].rANG). The concentration of IR-rANG in the medium containing 5
The reason for this apparent discrepancy is not yetmm d(1)-glucose in panels A and B (1.86 6 0.12 ng/ml and 4.16 6 0.72
ng/ml, respectively) were considered as the controls (100%). Each point known, but may be related to the use of different strains
represents the mean 6 sd of three dishes (*P # 0.05 and ***P # 0.005). of rats or the collection of tissue samples at differentSimilar results were obtained from another experiment.
time periods after the induction of diabetes with strepto-
zotocin.
Very few studies have described the effect of high
glucose levels on the expression of RAS genes in renalinhibited the increases in DAG and PKC activity stimu-
proximal tubular cells in vitro. In preliminary studies oflated by high glucose levels (25 mm).
heterologous opossum kidney (OK) cells, we reported
Effect of D(1)-glucose and Tolrestat on the cellular [36] that high glucose down-regulates the expression of
ANG mRNA level in IRPTCs RAS genes in OK cells. In more recent studies of a
subclone (OK 27) of the OK cells stably transfected withFigure 11 shows that a high glucose concentration
(25 mm) stimulated the accumulation of the ANG mRNA the plasmid, pOGH (ANG N-1498/118), we found that
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Fig. 8. Effect of D(1)-glucose and Tolrestat
on the cellular levels of myoinositol, sorbitol,
and fructose in IRPTCs. Cells were incubated
for 24 hours in the presence of 5 mm d(1)-
glucose, 25 mm d(1)-glucose, or 25 mm d(1)-
glucose plus Tolrestat (1024 m). Cells were har-
vested after 24 hours of incubation and assayed
for sorbitol, fructose, and myoinositol. The lev-
els of myoinositol (93.74 6 2.32 nmol/mg), sor-
bitol (0.08 6 0.003 nmol/mg), and fructose
(0.248 6 0.06 nmol/mg) in the cells incubated
in low d(1)-glucose (5 mm) in the absence
of Tolrestat were considered as the controls
(100%). Each point represents the mean 6
sd of five dishes of cells (***P # 0.005). Sym-
bols are: (j) control, 5 mm glucose; (h) cells
incubated in 25 mm d(1)-glucose; ( ) cells
incubated in 25 mm d(1)-glucose plus 1024
Tolrestat. Similar results were obtained from
another experiment.
are not known. One possible explanation might be that
a heterogenous population of OK cells was used in the
previous studies (obtained from the American Tissue
Culture Collection) [36], whereas our recent studies [37]
used a subclone (OK 27) of the OK cells obtained from
the American Tissue Culture Collection. Clearly, more
studies are warranted to clarify this discrepancy.
A novel finding of the study is that exposure of
IRPTCs to high concentrations of d(1)-glucose stimu-
lates the expression of the ANG in a concentration-
dependent manner (Fig. 1). We did not observe any stimu-
lation of the expression of ANG by l-glucose, d-mannitol,
or 2-deoxy-d-glucose (Fig. 2), indicating that the effect
of high d(1)-glucose levels on the expression of ANG
in IRPTCs is independent of changes in osmolarity andFig. 9. Effect of D(1)-glucose and Tolrestat on the cellular levels of
is probably mediated via the metabolism of d(1)-glucose.diacyglycerol (DAG) in IRPTCs. After a 30-minute incubation in media
with 5 mm d(1)-glucose, 25 mm d(1)-glucose, or 25 mm D(1)-glucose Our study also demonstrated that inhibition of aldose
plus Tolrestat (1024 m). Cells were harvested and assayed for DAG levels. reductase with Tolrestat blocked the stimulatory effectThe levels of DAG activity in the cells are expressed as nanomol per
of 25 mm d(1)-glucose on the expression of ANG inmg of protein. Each point represents the mean 6 sd of six determinations
(*P # 0.05). Similar results were obtained from another experiment. IRPTCs (Fig. 3). Furthermore, the addition of stauro-
sporine (Fig. 4A) and H-7 (Fig. 4B) also blocked the
stimulatory effect of high d(1)-glucose on the expression
of ANG in IRPTCs, suggesting that the effect of high25 mm d(1)-glucose stimulated the expression of the rat
levels of glucose is mediated, at least in part, via theANG gene promoter activity in OK cells [37]. We also
polyol pathway as Tilton et al suggested [38]. Activationreported that this increased promoter activity was
of the polyol pathway results in stimulation of de novoblocked by H-7 and staurosporine but not by Rp-cAMP
synthesis of DAG, which subsequently could stimulate(an inhibitor of protein kinase A I and II) [37], suggesting
the PKC activity in IRPTCs. The involvement of PKCthat the effect of glucose on the expression of the ANG
in the expression of ANG in IRPTCs is further supportedgene was mediated via the PKC signal transduction path-
by the observation that the addition of PMA stimulatedway. Currently, the reasons for the discrepancy between
the previous [36] and our recent studies [37] in OK cells the expression of ANG in IRPTCs (Fig. 5). Consistent
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levels [39]. The observation that the addition of PMA
abolished the inhibitory effect of Tolrestat on the expres-
sion of ANG in IRPTCs (Fig. 7) suggests that direct
activation of PKC activity by PMA could stimulate the
ANG expression independently of the polyol pathway.
These studies also suggest that the PKC activation occurs
downstream of the polyol pathway stimulated by high
levels of glucose.
To examine whether the effect of glucose could be
mediated via the de novo synthesis of DAG and subse-
quent activation of PKC activity, we assayed the cellular
levels of sorbitol, fructose, DAG, and PKC activity in
IRPTCs exposed to high glucose in the presence or ab-
sence of Tolrestat. Indeed, culture of IRPTCs in 25 mm
d(1)-glucose dramatically increased the intracellular
level of sorbitol and fructose (Fig. 8) and markedly in-
creased the levels of DAG (Fig. 9) and membrane PKC
activity (Fig. 10) compared with IRPTCs cultured in
medium containing 5 mm glucose. The addition of Tolres-
tat (1024 m) blocked the increase in sorbitol, fructose,
and DAG levels and PKC activity stimulated by 25 mm
d(1)-glucose (Figs. 8, 9, and 10). These data provide
additional support to the notion that the effect of a high
level of glucose (25 mm) on the expression of the ANG
in IRPTCs is mediated, at least in part, via the de novo
synthesis of DAG and the activation of PKC activity.
Apparently, more experiments are warranted to deter-
mine the isoform(s) of PKC involved. Cellular myoinosi-
tol levels were also quantitated in IRPTCs exposed to
25 mm glucose in the presence or absence of Tolrestat
(Fig. 8). Myoinositol levels are considerably decreased
in some tissues from diabetic animals, and some have
interpreted this change as evidence for decreased phos-
phoinositide turnover and decreased DAG production,
possibly leading to decreased PKC activity [40]. Our
studies were in agreement with Ziyadeh et al [41], how-
ever, that cellular myoinositol levels in IRPTCs were
unaffected by glucose or Tolrestat.
Fig. 10. Effect of D(1)-glucose and Tolrestat on the protein kinase C Finally, the effects of glucose on ANG appear to occur
(PKC) activity in IRPTCs. After 60 minutes of incubation in media
at the mRNA level. Indeed, exposure of IRPTCs towith 5 mm d(1)-glucose, 25 mm d(1)-glucose, or 25 mm d(1)-glucose
a high glucose concentration (25 mm) stimulated theplus Tolrestat (1024 m), cells were harvested, and cytosol and membrane
fractions were separated and assayed for PKC activity. The levels of expression of the ANG mRNA by twofold (P # 0.05)
PKC activity were expressed as picomol of 32P-ATP incorporated per
compared with levels in control cells (that is, 5 mm glu-minute per mg protein. The effect of 25 mm glucose, 25 mm glucose
cose; Fig. 11). The addition of Tolrestat (1024 m) com-plus Tolrestat (1024 m) is compared to the 5 mm glucose (control). Each
point represents the mean 6 sd of six determinations (*P # 0.05). pletely blocked the stimulatory effect of 25 mm d(1)-
Similar results were obtained from another experiment.
glucose. Currently, it is uncertain whether glucose could
increase the transcriptional level or might affect the sta-
bility of the ANG mRNA in IRPTCs. Studies are under-
way in our laboratory to investigate these possibilities.with these findings, the stimulatory effect of PMA was
abolished after a 24-hour preincubation of IRPTCs with In these studies, we have not quantitated the levels of
Ang II in the medium to demonstrate a parallel increase5 mm d(1)-glucose in the presence of 1025 m PMA (Fig.
6B) compared with the control cells without the preincu- of ANG and Ang II in the medium stimulated by high
glucose levels. Studies by Tang et al [27], however, havebation with PMA (Fig. 6A). These results are consistent
with the notion that the prolonged exposure to PMA will shown that the Ang II is presented in the incubation
medium of IRPTCs. Clearly, more experiments are war-down-regulate the PKC activity and protein expression
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Fig. 11. Effect of D(1)-glucose and Tolrestat
on the expression of rat ANG mRNA in
IRPTCs. After a 24-hour incubation in media
with 5 mm d(1)-glucose, 25 mm d(1)-glucose,
or 25 mm plus Tolrestat (1024 m), cells were
harvested and assayed for ANG mRNA levels
with a RT-PCR assay. The DNA fragments
of the RT-PCR reaction mixture were sepa-
rated on a 1.5% agarose gel and were then
transferred onto a nitrocellulose membrane.
Subsequently, the membrane was blotted with
a 32P-labeled oligonucleotide corresponding to
the nucleotides N1944 to N11020 of rat ANG
and N1418 to N1448 of rat G-3-PDH, respec-
tively. The relative densities of the PCR band
of ANG (629 bp DNA fragment) were com-
pared with the G-3-PDH control (523 bp
DNA fragment; A). The level of ANG mRNA
in the cells incubated in low d(1)-glucose (5
mm; that is, a ratio of 0.83 6 0.17 unit: ANG/
G-3-PDH), in the absence of Tolrestat was
considered as the control (100%; B). Each
point represents the mean 6 sd of three dishes
(*P # 0.05). Similar results were obtained
from another experiment.
ranted to correlate the levels of expression of the ANG PKC might be useful agents for the prevention and/or
and Ang II in the medium, and studies are underway in attenuation of glucose-induced ANG gene expression
our laboratory. and consequently development of diabetic nephropathy.
In summary, our studies showed that high d(1)-glu- However, it remains to be investigated whether aldose
cose levels directly stimulate the expression of the ANG reductase inhibitors may be beneficial in the long term
gene in IRPTCs. We have further demonstrated that in the treatment of diabetic nephropathy.
the stimulatory effect of high glucose was blocked by
Tolrestat, staurosporine, and H-7, implicating the ACKNOWLEDGMENTS
involvement of both the polyol pathway and the PKC
This work was supported by grants from the Medical Researchsignal transduction pathway in the overexpression of re-
Council of Canada (MT-13420 to J.S.D.C. and MT-12573 to J.G.F.)
nal ANG gene under hyperglycemic conditions. These and from the National Institutes of Health of USA (HL-48455 to
J.R.I. and DK-50836 to S.S.T.). We thank Mrs. Ilona Schmidt for herresults suggest that the aldose reductase inhibitors and
Zhang et al: Tolrestat, PKC and ANG gene in proximal tubular cells 463
secretarial assistance and Dr. Kenneth D. Roberts for his valuable of proximal tubular cells in culture. Biochem Biophys Res Commun
179:902–909, 1991comments. We also thank Wyeth-Ayerst Research (Princeton, NJ,
USA) for the gift of Tolrestat. 17. Wolf G, Killen PD, Neilson EG: Intracellular signalling of tran-
scription and secretion of type IV collagen after angiotensin II-
Reprint requests to John S.D. Chan, Ph.D., University of Montreal, induced cellular hypertrophy in cultured proximal tubular cells.
Cell Regul 2:219–227, 1991Maisonneuve-Rosemont Hospital, Research Center, 5415 boulevard de
l’Assomption, Montreal, Quebec, Canada H1T 2M4. 18. Rocco M, Chen Y, Goldfarb S, Ziyadeh FN: Elevated glucose
stimulates TGF-b gene expression and bioactivity in proximal tu-
bule. Kidney Int 41:107–114, 1992
19. Wolf G, Zahner G, Mondorf U, Schoeppe W, Stahl RAK:APPENDIX
Angiotensin II stimulates cellular hypertrophy of LLC-PK1 cells
through the AT1 receptor. Nephrol Dial Transplant 8:128–133,Abbreviations used in this article are: ACE, angiotensin-converting
1993enzyme; ANG, angiotensinogen; Ang II, angiotensin II; DAG, diacyl-
20. Wolf G, Mueller E, Stahl R, Ziyadeh FN: Angiotensin II-glycerol; EDTA, ethylenediaminetetraacetic acid; FBS, fetal bovine
induced hypertrophy of cultured murine proximal tubular cells isserum; G-3-PDH, glyceraldehyde-phosphate dehydrogenase; IRPTCs,
mediated by endogenous transforming growth factor-b. J Clin In-immortalized rat proximal tubular cells; IR-rANG, immunoreactive-
vest 92:1366–1372, 1993rat angiotensinogen; OK, opossum kidney; PKC, protein kinase C;
21. Blayer AJ, Fumo P, Snipes ER, Goldfarb S, Simmons DA, Ziya-PMA, phorbol 12-myristate 13-acetate; RAS, renin-angiotensin system;
deh FN: Polyol pathway mediates high glucose-induced collagenRIA, radioimmunoassay; RT-PCR, reverse transcription-polymerase
synthesis in proximal tubule. Kidney Int 45:659–666, 1994chain reaction.
22. Donnelly S, Zhou XP, Huang J, Whiteside CI: Prevention of
early glomerulopathy with Tolrestat in the streptozotocin induced
REFERENCES diabetic rat. Biochem Cell Biol 74:355–362, 1996
23. Ishi H, Jirousek MR, Koya D, Takaji C, Xia P, Clermont A,1. Rabskin P, Rosenstock J: Blood glucose control and diabetic
Bursell SE, Kern TS, Ballas LM, Health WF, Stramm LE,complications. Ann Intern Med 105:254–263, 1986
Feener EP, King GL: Amelioration of vascular dysfunctions in2. Marie M, Chatellier G, Leblanc H, Guyene TT, Menard T,
diabetic rats by an oral PKCB inhibitor. Science 272:728–731, 1996Passa P: Prevention of diabetic nephropathy with enalapril in
24. Ingelfinger JR, Zuo WM, Fon EA, Ellison KE, Dzau VJ: Innormotensive diabetes with micro albuminia. BMJ 297:1092–1095,
situ hybridization evidence for angiotensinogen mRNA in the rat1988
proximal tubule: A hypothesis for the intrarenal renin angiotensin3. Bjorck S, Aureel M: Diabetes mellitus, the renin-angiotensin
system. J Clin Invest 85:417–423, 1990system and angiotensin-converting enzyme inhibition. Nephron
25. Wolf G, Neilson EG: Angiotensin II as a hypertrophogenic cyto-55:10–20, 1990
kine for proximal tubular cells. Kidney Int 43(Suppl 39):S100–S107,4. De Jong PE, Heeg JE, Apperloo AJ, Seauwe DD: Angiotensin
1992I converting enzyme inhibition: Clinical effects in chronic and renal
26. Chen M, Harris MP, Rose D, Smart A, He X-R, Kretzler M,disease. Am J Kidney Dis 17:855–888, 1991
Briggs JP, Schnermann J: Renin and renin mRNA in proximal5. Lewis EJ, Hunsicker LG, Bain RP, Rhode RD: The effect of
tubule of the rat kidney. J Clin Invest 94:237–243, 1994angiotensin-converting enzyme inhibition on diabetic nephropa-
27. Tang SS, Jung FF, Diamant D, Brown D, Bachinsky D, Hellmanthy. N Engl J Med 329:1456–1462, 1993
P, Ingelfinger JR: Temperature-sensitive SV 40 immortalized rat6. Bakris GL: Angiotensin-converting enzyme inhibitors and the pro-
proximal tubule cell line has functional renin-angiotensin system.gression of diabetic nephropathy. Ann Intern Med 118:643–644,
Am J Physiol 268:F435–F436, 19951993
28. Wang L, Lei C, Zhang S-L, Roberts KD, Tang S-S, Ingelfinger7. Ishidoya S, Morrissey J, McCracken R, Reyes A, Klahr S: An-
JR, Chan JSD: Synergistic effect of dexamethasone and isoprotere-giotensin II receptor antagonist ameliorates renal tubulointerstitial
nol on the expression of angiotensinogen in immortalized rat proxi-fibrosis caused by unilateral ureteral obstruction. Kidney Int
mal tubular cells. Kidney Int 53:287–295, 199847:1285–1294, 1995
29. Samuels HH, Standby F, Shapiro LE: Control of growth hormone8. Ickikawa I: Will angiotensin II receptor antagonists be renoprotec-
synthesis in cultured GH cells by 3,5,39-triodo-L-thyronine andtive in humans? Kidney Int 50:684–692, 1996
glucocorticoid agonists and antagonists: Studies on the indepen-9. Gandhi SD, Ryder DH, Brown NJ: Losartan blocks aldosterone
dent and synergistic regulation of the growth hormone response.and renal vascular responses to angiotensin II in humans. Hyperten-
Biochemistry 18:715–721, 1979sion 28:961–966, 1996
30. Robison WG Jr, Laver NN, Jacot JL, Glover JP, Basso MD,10. Ayo SH, Radnik RA, Class IIWF, Garoni JA, Rampt ER, Ap-
Blouin P, Hohman TC: Diabetic-like retinopathy ameliorated withpling DR, Kriesberg JI: Increased extracellular matrix synthesis
the aldose reductase inhibitor WAY-121,509. Invest Ophthalmoland mRNA in mesangial cells grown in high-glucose medium. Am
Vis Sci 37:1149–1156, 1996J Physiol 260:F185–F191, 1991
31. Ohkubo H, Kageyama R, Ujihara M, Hirose T, Inayama S, Na-11. Nahman JRNS, Leonhart KL, Cosio FG, Hebert CL: Effects of
kanishi S: Cloning and sequence analysis of cDNA for rat angioten-high glucose on cellular proliferation and fibronectin by cultured
sinogen. Proc Natl Acad Sci USA 80:2196–3000, 1983human mesangial cells. Kidney Int 41:396–402, 1992
32. Tso JY, Sun XH, Kao TH, Reece KS, Wu R: Isolation and charac-12. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN: High
terization of rat and human glyceraldehyde-3-phosphate dehydro-glucose-induced proliferation in mesangial cells is reversed by auto-
genase cDNAs: Genomic complexity and molecular evolution ofcrine TGF-b. Kidney Int 42:647–656, 1992
the gene. Nucl Acids Res 13:2485–2502, 198513. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of
33. Correa-Rotter R, Hostetter TH, Rosenberg ME: Renin andcollagen gene expression and protein synthesis in murine mesangial
cells by high glucose is mediated by autocrine activation of trans- angiotensinogen gene expression in experimental diabetes mellitus.
Kidney Int 41:796–804, 1992forming growth factor-b. J Clin Invest 93:536–542, 1994
14. Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S, 34. Kalinyak JE, Sechi LA, Griffin CA, Don BR, Tavangar K,
Kraemer FB, Hoffman AR, Schambelan M: The renin-angioten-Haverty TP: High glucose induces cell hypertrophy and stimulates
collagen gene transcription in proximal tubule. Am J Physiol sin system in streptozotocin-induced diabetes mellitus in the rat.
J Am Soc Nephrol 4:1337–1345, 1993259:F704–F714, 1990
15. Wolf G, Neilson EG: Angiotensin II induces cellular hypertrophy 35. Anderson S, Jung FF, Ingelfinger JR: Renal renin-angiotensin
system in diabetes: Functional, immunohistochemical, and molecu-in cultural murine tubular cells. Am J Physiol 259:F768–F777, 1990
16. Wolf G, Neilson EG, Goldfarb S, Ziyadeh FN: The influence lar biological correlations. Am J Physiol 265:F477–F486, 1993
36. Ingelfinger JR, Boubounes B, Jung FF, Tang SS: High glucoseof glucose concentration on angiotensin II-induced hypertrophy
Zhang et al: Tolrestat, PKC and ANG gene in proximal tubular cells464
downregulates expression of renin angiotensin system (RAS) in 39. Hug H, Sane TF: Protein kinase C isozymes: Divergence in signal
transduction? Biochem J 291:329–343, 1993opossum kidney cell. (abstract) Pediatr Nephrol 29:344A, 1991
40. Greene DA, Sima AAF, Stevens MJ, Feldman EL, Lattimer SA:37. Wang TT, Wu X-H, Zhang S-L, Chan JSD: The effect of glucose
Complications: Neuropathy, pathogenic considerations. Diabeteson the expression of angiotensinogen gene in opossum kidney cells.
Care 15:1902–1925, 1992
Kidney Int 53:312–319, 1998 41. Ziyadeh FN, Simmons DA, Snipes ER, Goldfarb S: Effect of
38. Tilton RG, Baier D, Harlow JE, Smith SR, Ostrow E, William- myoinositol on cell proliferation and collagen transcription and
son JR: Diabetes-induced glomerular dysfunction: Link to a more secretion in proximal tubule cells cultured in elevated glucose.
J Am Soc Nephrol 1:1220–1229, 1991reduced ratio of NADH/NAD1. Kidney Int 41:778–788, 1992
